Baldwin Wealth Partners’s Seagen Inc. Common Stock SGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-26
Closed -$4K 839
2022
Q3
$4K Hold
26
﹤0.01% 586
2022
Q2
$5K Hold
26
﹤0.01% 596
2022
Q1
$4K Buy
26
+1
+4% +$135 ﹤0.01% 621
2021
Q4
$4K Hold
25
﹤0.01% 584
2021
Q3
$4K Hold
25
﹤0.01% 597
2021
Q2
$4K Hold
25
﹤0.01% 603
2021
Q1
$3K Hold
25
﹤0.01% 589
2020
Q4
$4K Hold
25
﹤0.01% 508
2020
Q3
$5K Sell
25
-250
-91% -$41.9K ﹤0.01% 476
2020
Q2
$47K Buy
275
+250
+1,000% +$37.3K 0.01% 302
2020
Q1
$3K Hold
25
﹤0.01% 507
2019
Q4
$3K Buy
+25
New +$2.65K ﹤0.01% 509

Other funds holding SGEN

Baldwin Wealth Partners's SGEN Position: Q4 2022 in Review

Baldwin Wealth Partners sold out of Seagen Inc. Common Stock (SGEN) in Q4 2022, closing a stake of 26 shares — an estimated $4K sold.

Baldwin Wealth Partners first reported a position in SGEN in Q4 2019 and held it in 12 quarters. The position peaked at $47K in Q2 2020. 537 funds tracked by Wall St. Rank hold SGEN as of Q4 2022.

  • Baldwin Wealth Partners reported no remaining Seagen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Baldwin Wealth Partners sold 26 Seagen Inc. Common Stock shares in Q4 2022, an estimated $4K.
  • Baldwin Wealth Partners first reported a position in Seagen Inc. Common Stock in Q4 2019 and held it in 12 quarters.
  • Baldwin Wealth Partners's Seagen Inc. Common Stock position peaked at $47K in Q2 2020.
  • 537 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2022.

Based on Baldwin Wealth Partners's 13F filing for Q4 2022, filed 27 Jan 2023.